These variants and our knowledge of the roles of TDP-43 in ALS pathophysiology support the idea that TDP-43 acts through both loss-of-function mechanisms and gain-of-function mechanisms by promoting its aggregation [56,76]. Here, TARDBP is linked to amyotrophic lateral sclerosis.